Skip to main content
SpringerLink
Log in

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Cognitive deficits represent a core symptom cluster in schizophrenia (SZ) that is predictive of outcome but not effectively treated by current antipsychotics. Thus, there is a need for validated animal models for testing potential pro-cognitive drugs.

Objective

As kynurenic acid levels are increased in prefrontal cortex (PFC) of individuals with SZ, we acutely increased brain levels of this astrocyte-derived, negative modulator of alpha7 nicotinic acetylcholine receptors (α7nAChRs) by administration of its bioprecursor kynurenine and measured the effects on extracellular kynurenic acid and glutamate levels in PFC and also performance in a set-shifting task.

Results

Injections of kynurenine (100 mg/kg, i.p.) increased extracellular kynurenic acid (1,500%) and decreased glutamate levels (30%) in PFC. Kynurenine also produced selective deficits in set-shifting. Saline- and kynurenine-treated rats similarly acquired the compound discrimination and intra-dimensional shift (saline, 7.0 and 6.3 trials, respectively; kynurenine, 8.0 and 6.7). Both groups required more trials to acquire the initial reversal (saline, 15.3; kynurenine, 22.2). Only kynurenine-treated rats were impaired in acquiring the extra-dimensional shift (saline, 8.2; kynurenine, 21.3). These deficits were normalized by administering the α7nAChR positive allosteric modulator galantamine (3.0 mg/kg, i.p) prior to kynurenine, as trials were comparable between galantamine + kynurenine (7.8) and controls (8.2). Bilateral local perfusion of the PFC with galantamine (5.0 μM) also attenuated kynurenine-induced deficits.

Conclusions

These results validate the use of animals with elevated brain kynurenic acid levels in SZ research and support studies of drugs that normalize brain kynurenic acid levels and/or positively modulate α7nAChRs as pro-cognitive treatments for SZ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34:1161–1177

    Article  PubMed  Google Scholar 

  • Bauer D, Gupta D, Haroutunian V, Meador-Woodruff JH, Mccullumsmith RE (2008) Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res 104:108–120

    Article  PubMed  Google Scholar 

  • Baune BT, Suslow T, Beste C, Birosova E, Domschke K, Sehlmeyer C, Konrad C (2010) Association between genetic variants of the metabotropic glutamate receptor 3 (GRM3) and cognitive set shifting in healthy individuals. Genes Brain Behav 9:459–466

    PubMed  CAS  Google Scholar 

  • Birrell J, Brown V (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320–4324

    PubMed  CAS  Google Scholar 

  • Brooks JM, Thomsen MS, Mikkelsen JD, Sarter M, Bruno JP (2010) Attentional set-shifting deficits in a neurodevelopmental animal model of schizophrenia—reversal with an alpha7 nAChR agonist. 368.08. 2010 Neuroscience Meeting Planner. Society for Neuroscience, San Diego, Online

    Google Scholar 

  • Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP (2008) Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiat 165:82–89

    Article  PubMed  Google Scholar 

  • Cabrera SM, Chavez CM, Corley SR, Kitto MR, Butt AE (2006) Selective lesions of the nucleus basalis magnocellularis impair cognitive flexibility. Behav Neurosci 120:298–306

    Article  PubMed  Google Scholar 

  • Chen EY, Tam DK, Dunn EL, Miao MY, Yeung WS, Wong CK, Chan WF, Tang WN (2005) Neurocognitive and clinical predictors for vocational outcome following first episode schizophrenia: a 3 year prospective study. Schizophr Bull 31:320

    Google Scholar 

  • Chess AC, Simoni MK, Alling TE, Bucci DJ (2007) Elevations of endogenous kynurenic acid produce spatial working memory deficits. Schizophr Bull 33:797–804

    Article  PubMed  Google Scholar 

  • Chess AC, Landers AM, Bucci DJ (2009) L-Kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning. Behav Brain Res 201:325–331

    Article  PubMed  CAS  Google Scholar 

  • Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28:771–784

    Article  PubMed  CAS  Google Scholar 

  • Dalton GL, Ma LM, Phillips AG, Floresco SB (2011) Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning. Psychopharmacology 216:525–535

    Article  PubMed  CAS  Google Scholar 

  • Darrah JM, Stefani MR, Moghaddam B (2008) Interaction of N-methyl-d-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. Behav Pharmacol 19:225–234

    Article  PubMed  CAS  Google Scholar 

  • Dias R, Robbins TW, Roberts AC (1996) Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380:69–72

    Article  PubMed  CAS  Google Scholar 

  • Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA (2005) Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology 179:77–84

    Article  PubMed  CAS  Google Scholar 

  • Erhardt S, Blennow K, Nordin C, Skogh E, Lindström LH, Engberg G (2001) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313:96–98

    Article  PubMed  CAS  Google Scholar 

  • Erhardt S, Schwieler L, Emanuelsson C, Geyer M (2004) Endogenous kynurenic acid disrupts prepulse inhibition. Biol Psychiat 56:255–260

    Article  PubMed  CAS  Google Scholar 

  • Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MT (2006) Multiple dopaminergic receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 31:297–309

    Article  PubMed  CAS  Google Scholar 

  • Floresco SB, Zhang Y, Enomoto T (2009) Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 204:396–409

    Article  PubMed  Google Scholar 

  • Gal EM, Sherman AD (1980) L-Kynurenine: its synthesis and possible regulatory function in brain. Neurochem Res 5:223–239

    Google Scholar 

  • Ghods-Sharifi S, Haluk DM, Floresco SB (2008) Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning. Neurobiol Learning Mem 89:567–573

    Article  Google Scholar 

  • Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72:21–28

    Article  PubMed  Google Scholar 

  • Gonzalez-Burgos G, Hashimoto T, Lewis DA (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiat Rep 12:335–344

    Article  Google Scholar 

  • Goto Y, Yang CR, Otani S (2010) Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol Psychiat 67:199–207

    Article  PubMed  Google Scholar 

  • Gruber AJ, Calhoon GG, Shusterman I, Schoenbaum G, Roesch MR, O’Donnell P (2010) More is less: a disinhibited prefrontal cortex impairs cognitive flexibility. J Neurosci 30:17102–17110

    Article  PubMed  CAS  Google Scholar 

  • Guidetti P, Hoffman GE, Melendez-Ferro M, Albuquerque EX, Schwarcz R (2007) Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55:78–92

    Article  PubMed  Google Scholar 

  • Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1–9

    Article  PubMed  CAS  Google Scholar 

  • Haluk DM, Floresco SB (2009) Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 34:2041–2052

    Article  PubMed  CAS  Google Scholar 

  • Heinrichs RW (2005) The primacy of cognition in schizophrenia. Am Psychol 60:229–242

    Article  PubMed  Google Scholar 

  • Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic expression: physiopathological implications. J Neurosci 21:7463–7473

    PubMed  CAS  Google Scholar 

  • Hyde TM, Crook JM (2001) Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J Chem Neuroanat 22:53–63

    Article  PubMed  CAS  Google Scholar 

  • Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69–108

    Article  PubMed  CAS  Google Scholar 

  • Keefe RSE (2007) Cognitive deficits in patients with schizophrenia: effects and treatment. J Clin Psychiat 68:8–13

    Article  Google Scholar 

  • Kehagia AA, Murray GK, Robbins TW (2010) Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20:199–204

    Article  PubMed  CAS  Google Scholar 

  • Kerns JG, Nuechterlein KH, Braver TS, Barch DM (2008) Executive functioning component mechanisms and schizophrenia. Biol Psychiat 64:26–33

    Article  PubMed  Google Scholar 

  • Konradsson-Geuken Å, Gash CR, Alexander KA, Pomerleu F, Huettl P, Gerhardt GA, Bruno JP (2009) Second-by-second analysis of alpha7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse 63:1069–1082

    Article  PubMed  CAS  Google Scholar 

  • Konradsson-Geuken Å, Wu HQ, Gash CR, Alexander KS, Campbell A, Sozeri Y, Pellicciari R, Schwarcz R, Bruno JP (2010) Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience 169:1848–1859

    Article  PubMed  CAS  Google Scholar 

  • Krystal JH, D’Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiat 7:125–143

    CAS  Google Scholar 

  • Lie CH, Specht K, Marshall JC, Fink GR (2006) Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. NeuroImage 30:1038–1049

    Article  PubMed  Google Scholar 

  • Lilienfeld S (2002) Galantamine – a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer’s disease. CNS Drug Rev 8:159–176

    Article  PubMed  CAS  Google Scholar 

  • Lindenmayer JP, Khan A (2011) Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. Schizophr Res 125:267–277

    Article  PubMed  Google Scholar 

  • Livingstone PD, Dickinson JA, Srinivasan J, Kew JN, Wonnacott S (2010) Glutamate–dopamine crosstalk in the rat prefrontal cortex is modulated by alpha7 nicotinic receptors and potentiated by PNU-120596. J Mol Med 40:171–176

    Google Scholar 

  • Lopes C, Pereira EFR, Wu HQ, Pranik P, Njar V, Schwarcz R, Albuquerque EX (2007) Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at α7* nicotinic receptors. J Pharmacol Exp Ther 322:48–58

    Article  PubMed  CAS  Google Scholar 

  • Mathew SV, Law AJ, Lipska BK, Davila-Garcia MI, Zamora ED, Mitkus SN, Vakkalanka R, Straub RE, Weinberger DR, Kleinman JE, Hyde TM (2007) Alpha 7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Hum Mol Gen 16:2921–2932

    Article  PubMed  CAS  Google Scholar 

  • McAlonan K, Brown VJ (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146:97–103

    Article  PubMed  Google Scholar 

  • McGaughy J, Ross RS, Eichenbaum H (2008) Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 153:63–71

    Article  PubMed  CAS  Google Scholar 

  • Miller CL, Llenos IC, Dulay JR, Barillo MM, Yolken RH, Weis S (2004) Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 15:618–629

    Article  PubMed  CAS  Google Scholar 

  • Miller CL, Llenos IC, Dulay JR, Weis S (2006) Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res 1073–1074:25–37

    Article  PubMed  Google Scholar 

  • Nilsson LK, Linderholm KR, Erhardt S (2006) Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons. J Neural Transm 113:557–571

    Article  PubMed  CAS  Google Scholar 

  • Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29–39

    Article  PubMed  Google Scholar 

  • Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009) CNTRICS final task selection: control of attention. Schizophr Bull 35:182–196

    Article  PubMed  Google Scholar 

  • Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kern WR, Freedman R (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiat 63:630–638

    Article  PubMed  CAS  Google Scholar 

  • Pantelis C, Barber FZ, Barnes TR, Nelson HE, Owen AM, Robbins TW (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37:251–270

    Article  PubMed  CAS  Google Scholar 

  • Parikh V, Sarter M (2008) Cholinergic mediation of attention—contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann NY Acad Sci 1129:225–235

    Article  PubMed  CAS  Google Scholar 

  • Pedersen CS, Goetghebeur P, Dias R (2009) Chronic infusion of PCP via osmotic mini- pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. J Neurosci Meth 185:66–69

    Article  CAS  Google Scholar 

  • Pocivavsek A, Wu H-Q, Potter MC, Elmer GI, Pellicciari R, Schwarcz R (2011) Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology 36:2357–2367

    Article  PubMed  CAS  Google Scholar 

  • Potkin SG, Fleming K, Jin Y, Gulasekaram B (2001) Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J Clin Psychopharm 21:479–483

    Article  CAS  Google Scholar 

  • Prouteau A, Verdoux N, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E (2005) Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res 77:343–353

    Article  PubMed  Google Scholar 

  • Ragozzino ME, Wilcox C, Raso M, Kesner RP (1999) Involvement of rodent prefrontal cortex subregions in strategy switching. Behav Neurosci 113:32–41

    Article  PubMed  CAS  Google Scholar 

  • Ragozzino ME, Ragozzino KE, Mizumori SJY, Kesner RP (2002) The role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behav Neurosci 116:105–115

    Article  PubMed  Google Scholar 

  • Rassoulpour A, Wu H-Q, Ferré S, Schwarcz R (2005) Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. J Neurochem 93:762–765

    Article  PubMed  CAS  Google Scholar 

  • Robbins TW (2007) Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans Roy Soc B 362:917–932

    Article  CAS  Google Scholar 

  • Robbins TW, Arnsten AFT (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267–287

    Article  PubMed  CAS  Google Scholar 

  • Robbins TW, Roberts AC (2007) Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 17:151–160

    Article  Google Scholar 

  • Rollnik JD, Borsutzky M, Huber TJ, Mogk H, Seifert J, Emrich HM, Schneider U (2002) Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 45:74–80

    Article  PubMed  CAS  Google Scholar 

  • Rygula R, Walker SC, Clarke HF, Robbins TW, Roberts AC (2010) Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 30:14552–14559

    Article  PubMed  CAS  Google Scholar 

  • Sathyasaikumar KV, Stachowski EK, Wonodi I, Robers RC, Rassoulpour A, McMahon RP, Schwarcz R (2010). Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophrenia Bulletin (in press)

  • Scarr E, Cowie TF, Kanellakis S, Sundram S, Pantelis C, Dean B (2009) Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Mol Psychiatr 14:1017–1023

    Article  CAS  Google Scholar 

  • Schubert MH, Young KA, Hicks PB (2006) Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychiat 60:530–533

    Article  PubMed  CAS  Google Scholar 

  • Schwarcz R, Rassoulpour A, Wu H-Q, Medoff D, Tamminga CA, Roberts RC (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiat 50:521–530

    Article  PubMed  CAS  Google Scholar 

  • Shank RP, Leo GC, Zielke HR (1993) Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of d-[1-13C]glucose metabolism. J Neurochem 61:315–323

    Article  PubMed  CAS  Google Scholar 

  • Shepard PD, Joy B, Clerkin L, Schwarcz R (2003) Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat. Neuropsychopharmacology 28:1454–1462

    Article  PubMed  CAS  Google Scholar 

  • Shigeta M, Homma A (2001) Donepezil for Alzheimer’s disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev 7:353–368

    Article  PubMed  CAS  Google Scholar 

  • Speciale C, Hares K, Schwarcz R, Brookes N (1989) High-affinity uptake of l-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes. J Neurosci 9:2066–2072

    PubMed  CAS  Google Scholar 

  • Stefani MR, Moghaddam B (2005) Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci 119:420–428

    Article  PubMed  CAS  Google Scholar 

  • Stefani MR, Moghaddam B (2010) Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade. Eur J Pharmacol 639:26–32

    Article  PubMed  CAS  Google Scholar 

  • Stefani MR, Groth K, Moghaddam B (2003) Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci 117:728–737

    Article  PubMed  CAS  Google Scholar 

  • Swartz KJ, During MJ, Freese A, Beal MF (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 10:2965–2973

    PubMed  CAS  Google Scholar 

  • Tait DS, Brown VJ (2008) Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats. Behav Brain Res 187:100–108

    Article  PubMed  CAS  Google Scholar 

  • Vasey MW, Thayer JF (1987) The continuing problem of false positives in repeated measures ANOVA in psychophysiology—a multivariate solution. Psychophysiology 24:479–489

    Article  PubMed  CAS  Google Scholar 

  • Volk DW, Lewis DA (2010) Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci 4:485–508

    Article  PubMed  Google Scholar 

  • Volk DW, Eggan SM, Lewis DA (2010) Alterations in metabotropic glutamate receptor 1 alpha and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiat 167:1489–1498

    Article  PubMed  Google Scholar 

  • Winterer G, Weinberger DR (2004) Genes, dopamine, and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683–690

    Article  PubMed  CAS  Google Scholar 

  • Wonodi I, Schwarcz R (2010) Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia. Schizophr Bull 36:211–218

    Article  PubMed  Google Scholar 

  • Wonodi I, Stine OC, Sathyasaikumar KV, Roberts RC, Mitchell BD, Hong LE, Kajii Y, Thaker GK, Schwarcz R (2011) Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatr 68:665–674

    Article  PubMed  CAS  Google Scholar 

  • Woo TUW, Shrestha K, Lamb D, Minns MM, Benes FM (2008) N-methyl-D-aspartate receptor and calbinding-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol Psychiat 64:803–809

    Article  PubMed  CAS  Google Scholar 

  • Wu H-Q, Pelliciari R, Schwarcz R (2006) Bidirectional regulation of extracellular dopamine by endogenous kynurenic acid in the rat medial prefrontal cortex. Soc Neurosci Abst 32:624.3

    Google Scholar 

  • Wu H-Q, Pereira EFR, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R (2010) The astrocyte-derived alpha7 nicotonic receptor antagonist kynurenic acid controls extracellular glutamate levels in prefrontal cortex. J Mol Neurosci 40:204–210

    Article  PubMed  CAS  Google Scholar 

  • Zmarowski A, Wu H-Q, Brooks JM, Potter MC, Pellicciari R, Schwarcz R, Bruno JP (2009) Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur J Neurosci 29:529–538

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors’ research was supported by a grant from the National Institutes of Health (MH083729) to JPB and RS.

Disclosures/conflicts of interest

During the past 3 years, RS has received research support from Mitsubishi-Tanabe (Yokohama, Japan) and Bristol-Myers-Squibb (Wallingford, CT, USA) and served as a consultant to Merck (West Point, PA, USA). The other authors declare that, except for income received from the primary employer, no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research or professional service, and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.

Author information

Authors and Affiliations

  1. Department of Psychology and Neuroscience, The Ohio State University, 1835 Neil Ave., Columbus, OH, 43210, USA

    Kathleen S. Alexander & John P. Bruno

  2. Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, 21228, USA

    Hui-Qiu Wu & Robert Schwarcz

Authors
  1. Kathleen S. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui-Qiu Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Schwarcz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John P. Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John P. Bruno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexander, K.S., Wu, HQ., Schwarcz, R. et al. Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmacology 220, 627–637 (2012). https://doi.org/10.1007/s00213-011-2539-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-011-2539-2

Keywords

Search

Navigation